PRGO – Perrigo Company plc
PRGO — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
11.52
Margin Of Safety %
-9
Put/Call OI Ratio
0.28
EPS Next Q Diff
-0.38
EPS Last/This Y
12.53
EPS This/Next Y
0.18
Price
9.53
Target Price
16
Analyst Recom
2.17
Performance Q
-30.69
Upside
-2,473.1%
Beta
0.55
Ticker: PRGO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | PRGO | 12.35 | 0.97 | 3.82 | 11431 |
| 2026-03-04 | PRGO | 11.69 | 0.96 | 1.57 | 11601 |
| 2026-03-05 | PRGO | 11.21 | 0.96 | 2.84 | 11655 |
| 2026-03-09 | PRGO | 10.29 | 0.81 | 0.48 | 13447 |
| 2026-03-10 | PRGO | 10.1 | 0.75 | 0.14 | 14505 |
| 2026-03-11 | PRGO | 9.81 | 0.53 | 0.04 | 13149 |
| 2026-03-12 | PRGO | 9.42 | 0.46 | 0.19 | 14438 |
| 2026-03-17 | PRGO | 10.31 | 0.33 | 0.09 | 18673 |
| 2026-03-18 | PRGO | 9.94 | 0.33 | 0.18 | 18721 |
| 2026-03-19 | PRGO | 9.65 | 0.32 | 0.13 | 18803 |
| 2026-03-20 | PRGO | 9.24 | 0.29 | 0.39 | 18412 |
| 2026-03-23 | PRGO | 9.56 | 0.31 | 0.02 | 14651 |
| 2026-03-24 | PRGO | 9.65 | 0.29 | 0.03 | 15688 |
| 2026-03-25 | PRGO | 9.69 | 0.28 | 0.05 | 15788 |
| 2026-03-26 | PRGO | 9.38 | 0.28 | 0.07 | 15848 |
| 2026-03-27 | PRGO | 9.53 | 0.28 | 0.02 | 16153 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | PRGO | 13.20 | -16.1 | 14.9 | 2.76 |
| 2026-03-02 | PRGO | 12.35 | -46.5 | -84.6 | 2.38 |
| 2026-03-03 | PRGO | 11.38 | -44.4 | 954.2 | 2.38 |
| 2026-03-04 | PRGO | 11.69 | -44.4 | 947.4 | 2.24 |
| 2026-03-05 | PRGO | 11.21 | -44.4 | 951.7 | 2.24 |
| 2026-03-06 | PRGO | 10.72 | -44.4 | 951.9 | 2.24 |
| 2026-03-09 | PRGO | 10.29 | -44.4 | 951.5 | 2.24 |
| 2026-03-10 | PRGO | 10.10 | -44.4 | 950.3 | 2.24 |
| 2026-03-11 | PRGO | 9.81 | -44.4 | 950.8 | 2.24 |
| 2026-03-12 | PRGO | 9.42 | -44.4 | 951.5 | 2.24 |
| 2026-03-13 | PRGO | 9.31 | -44.4 | 949.9 | 2.24 |
| 2026-03-17 | PRGO | 10.32 | -44.4 | 947.0 | 2.24 |
| 2026-03-18 | PRGO | 9.95 | -44.4 | 952.4 | 2.24 |
| 2026-03-19 | PRGO | 9.65 | -44.4 | 952.1 | 2.24 |
| 2026-03-20 | PRGO | 9.24 | -44.4 | 952.8 | 2.24 |
| 2026-03-23 | PRGO | 9.57 | -44.4 | 948.6 | 2.24 |
| 2026-03-24 | PRGO | 9.64 | -44.4 | 950.0 | 2.24 |
| 2026-03-25 | PRGO | 9.69 | -44.4 | 950.2 | 2.24 |
| 2026-03-26 | PRGO | 9.38 | -44.4 | 952.5 | 2.24 |
| 2026-03-27 | PRGO | 9.53 | -44.4 | 949.9 | 2.24 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | PRGO | 1.60 | 1.19 | 11.09 |
| 2026-03-02 | PRGO | 1.60 | 3.99 | 11.09 |
| 2026-03-03 | PRGO | 1.60 | 3.99 | 11.09 |
| 2026-03-04 | PRGO | 1.60 | 3.99 | 11.09 |
| 2026-03-05 | PRGO | 1.60 | 3.99 | 11.09 |
| 2026-03-06 | PRGO | 1.60 | 3.99 | 11.09 |
| 2026-03-09 | PRGO | 1.60 | 3.66 | 11.09 |
| 2026-03-10 | PRGO | 1.43 | 3.66 | 11.09 |
| 2026-03-11 | PRGO | 1.23 | 3.66 | 12.53 |
| 2026-03-12 | PRGO | 1.23 | 3.66 | 12.53 |
| 2026-03-13 | PRGO | 1.23 | 3.66 | 12.53 |
| 2026-03-17 | PRGO | 1.23 | 3.70 | 12.53 |
| 2026-03-18 | PRGO | 1.23 | 3.70 | 12.53 |
| 2026-03-19 | PRGO | 1.23 | 3.70 | 12.53 |
| 2026-03-20 | PRGO | 1.23 | 3.70 | 12.53 |
| 2026-03-23 | PRGO | 1.22 | 3.60 | 12.53 |
| 2026-03-24 | PRGO | 1.22 | 3.60 | 12.53 |
| 2026-03-25 | PRGO | 1.23 | 3.60 | 11.52 |
| 2026-03-26 | PRGO | 1.23 | 3.60 | 11.52 |
| 2026-03-27 | PRGO | 1.23 | 3.60 | 11.52 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.77
Avg. EPS Est. Current Quarter
0.33
Avg. EPS Est. Next Quarter
0.39
Insider Transactions
1.23
Institutional Transactions
3.6
Beta
0.55
Average Sales Estimate Current Quarter
1031
Average Sales Estimate Next Quarter
997
Fair Value
8.7
Quality Score
34
Growth Score
31
Sentiment Score
60
Actual DrawDown %
81.3
Max Drawdown 5-Year %
-77.2
Target Price
16
P/E
Forward P/E
3.96
PEG
P/S
0.31
P/B
0.45
P/Free Cash Flow
9.04
EPS
-10.28
Average EPS Est. Cur. Y
2.24
EPS Next Y. (Est.)
2.42
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-33.51
Relative Volume
0.91
Return on Equity vs Sector %
-75.9
Return on Equity vs Industry %
-55.7
EPS 1 7Days Diff
-0.4
EPS 1 30Days Diff
-0.4
EBIT Estimation
949.9
◆
PRGO
Healthcare
$9.53
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
32.7
Range 1M
8%
Sup Dist
3.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-23%
EPS NY
13.7%
52W%
1.5%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+240.3% upside
Upside
+240.3%
Quality
34
MoS
-9%
Perrigo Company plcSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 8100
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
PRGO
Latest News
—
Caricamento notizie per PRGO…
stock quote shares PRGO – Perrigo Company plc Stock Price stock today
news today PRGO – Perrigo Company plc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRGO – Perrigo Company plc yahoo finance google finance
stock history PRGO – Perrigo Company plc invest stock market
stock prices PRGO premarket after hours
ticker PRGO fair value insiders trading